IE920437A1 - Synthetic peptides for detoxification of bacterial¹endotoxins and for the prevention and treatment of septic¹shock - Google Patents

Synthetic peptides for detoxification of bacterial¹endotoxins and for the prevention and treatment of septic¹shock

Info

Publication number
IE920437A1
IE920437A1 IE043792A IE920437A IE920437A1 IE 920437 A1 IE920437 A1 IE 920437A1 IE 043792 A IE043792 A IE 043792A IE 920437 A IE920437 A IE 920437A IE 920437 A1 IE920437 A1 IE 920437A1
Authority
IE
Ireland
Prior art keywords
lys
peptide
phe
leu
endotoxin
Prior art date
Application number
IE043792A
Other languages
English (en)
Other versions
IE83655B1 (en
Inventor
Massimo Porro
Original Assignee
Massimo Porro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of IE83655B1 publication Critical patent/IE83655B1/en
Application filed by Massimo Porro filed Critical Massimo Porro
Publication of IE920437A1 publication Critical patent/IE920437A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE043792A 1991-02-11 1992-02-10 Synthetic peptides for detoxification of bacterial¹endotoxins and for the prevention and treatment of septic¹shock IE920437A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
USUNITEDSTATESOFAMERICA11/02/19916
US65874491A 1991-02-11 1991-02-11
US07/819,893 US5371186A (en) 1991-02-11 1992-01-16 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock

Publications (2)

Publication Number Publication Date
IE83655B1 IE83655B1 (en)
IE920437A1 true IE920437A1 (en) 1992-08-12

Family

ID=25229363

Family Applications (1)

Application Number Title Priority Date Filing Date
IE043792A IE920437A1 (en) 1991-02-11 1992-02-10 Synthetic peptides for detoxification of bacterial¹endotoxins and for the prevention and treatment of septic¹shock

Country Status (16)

Country Link
US (2) US5371186A (zh)
EP (1) EP0623144B1 (zh)
JP (1) JPH07505606A (zh)
AT (1) ATE212355T1 (zh)
AU (1) AU665945B2 (zh)
CA (1) CA2123576A1 (zh)
DE (1) DE69232378T2 (zh)
DK (1) DK0623144T3 (zh)
ES (1) ES2172506T3 (zh)
FI (1) FI943396A (zh)
HU (1) HUT69707A (zh)
IE (1) IE920437A1 (zh)
IL (1) IL100811A (zh)
NZ (1) NZ241446A (zh)
TW (1) TW215441B (zh)
WO (1) WO1993014115A1 (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
US5371186A (en) * 1991-02-11 1994-12-06 Biosynth S.R.L. Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5610075A (en) * 1995-01-17 1997-03-11 Stahl-Rees; Marianne Competitive electrochemiluminescence assays for endotoxins using a ruthenium label
US5834430A (en) * 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
WO1998035665A1 (fr) * 1997-02-14 1998-08-20 Ajinomoto Co., Inc. Antagonistes des endotoxines
CA2298101A1 (en) 1997-07-31 1999-02-11 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
WO1999011281A1 (en) 1997-09-05 1999-03-11 Dana-Farber Cancer Institute The use of agents which bind g proteins for treating septic shock
US6194562B1 (en) 1998-04-22 2001-02-27 Promega Corporation Endotoxin reduction in nucleic acid purification
US7078224B1 (en) * 1999-05-14 2006-07-18 Promega Corporation Cell concentration and lysate clearance using paramagnetic particles
US6951652B2 (en) * 1998-07-29 2005-10-04 Biosynth S.R.L. Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
US6116663A (en) * 1998-10-19 2000-09-12 Cercueils Vic Royal, Inc. Casket Lock
DE10117043A1 (de) * 2001-04-05 2002-11-07 Gerhard Puetz Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
WO2003094961A1 (en) * 2002-05-09 2003-11-20 Massimo Porro Improved polysaccharide and glycoconjugate vaccines_____________
KR101239242B1 (ko) 2002-08-02 2013-03-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 항원 조합물을 포함하는 나이세리아 백신 조성물
AU2002368447A1 (en) * 2002-12-06 2004-06-30 Biosynth S.R.L. Broad-spectrum lps based vaccines of unencapsulated strains ofhaemophilus influenzae and other pathogenic species of gram-negative bacteria
GB2408263A (en) * 2003-11-14 2005-05-25 Pacgen Biopharmaceuticals Inc Antimicrobial peptides with reduced hemolysis and methods of their use.
EP1706481A2 (en) 2003-12-23 2006-10-04 GlaxoSmithKline Biologicals S.A. Vaccine
EP1871787A2 (en) * 2005-04-11 2008-01-02 Sanofi Pasteur Polymyxin b analogs for lps detoxification
US7507718B2 (en) 2005-04-11 2009-03-24 Sanofi Pasteur Polymyxin B analogs for LPS detoxification
EP1712559A1 (en) * 2005-04-11 2006-10-18 Sanofi Pasteur Polymyxin B analogs for LPS detoxification
WO2007070381A2 (en) 2005-12-09 2007-06-21 Promega Corporation Nucleic acid purification with a binding matrix
DE602007003596D1 (de) 2006-06-12 2010-01-14 Glaxosmithkline Biolog Sa Impfstoff
ES2350430B1 (es) * 2009-05-28 2011-11-18 Fundacion De La Comunidad Valenciana Centro De Investigacion Principe Felipe,95%. Conjugado polimerico para el tratamiento de infecciones bacterianas
TWI548746B (zh) * 2009-08-06 2016-09-11 英特威特國際股份有限公司 防備豬胸膜肺炎之疫苗及製備該疫苗之方法
US8039613B2 (en) 2009-08-28 2011-10-18 Promega Corporation Methods of purifying a nucleic acid and formulation and kit for use in performing such methods
US8222397B2 (en) 2009-08-28 2012-07-17 Promega Corporation Methods of optimal purification of nucleic acids and kit for use in performing such methods
CA2792683A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Neisserial fhbp vaccine composition
KR101858840B1 (ko) * 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340012C (en) * 1987-08-17 1998-08-25 Trustees Of Leland Stanford Jr. University Peptide determinant associated with immunity
US5593966A (en) * 1989-03-31 1997-01-14 The United States Of America As Represented By The Department Of Health And Human Services Peptide derivatives of cytochrome b558 and their use as medicaments
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
ZA92943B (en) * 1991-02-11 1992-11-25 Porro Massimo Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
US5371186A (en) * 1991-02-11 1994-12-06 Biosynth S.R.L. Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock

Also Published As

Publication number Publication date
DE69232378T2 (de) 2002-10-31
DE69232378D1 (de) 2002-03-14
AU665945B2 (en) 1996-01-25
WO1993014115A1 (en) 1993-07-22
TW215441B (zh) 1993-11-01
IL100811A0 (en) 1992-09-06
EP0623144A1 (en) 1994-11-09
DK0623144T3 (da) 2002-05-13
US5371186A (en) 1994-12-06
ATE212355T1 (de) 2002-02-15
HUT69707A (en) 1995-09-28
EP0623144B1 (en) 2002-01-23
FI943396A0 (fi) 1994-07-15
IL100811A (en) 1999-07-14
ES2172506T3 (es) 2002-10-01
CA2123576A1 (en) 1993-07-22
NZ241446A (en) 1995-03-28
AU1691492A (en) 1993-08-03
FI943396A (fi) 1994-07-15
US5589459A (en) 1996-12-31
HU9401970D0 (en) 1994-09-28
JPH07505606A (ja) 1995-06-22

Similar Documents

Publication Publication Date Title
EP0623144B1 (en) Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock
IE83655B1 (en) Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock
Siemion et al. Tuftsin: on the 30-year anniversary of Victor Najjar’s discovery
JP4044140B2 (ja) インスリン誘導体類とその使用
EP0093652B1 (fr) Toxine synthétique ST, son procédé de préparation et son application comme agent vaccinant
AU683920B2 (en) Peptides for neutralizing the toxicity of lipid A
US6762166B2 (en) Synthetic complementary peptides and ophthalmologic uses thereof
Luker et al. Tracheal cytotoxin structural requirements for respiratory epithelial damage in pertussis
JPH06501938A (ja) ペプチドよりなるｈｉｖ複製阻害剤
JPH09509168A (ja) 痛みの処置のための新規なオピオイドペプチドおよびその使用
US5583198A (en) Amino acids, peptides or derivatives thereof coupled to fats
US6951652B2 (en) Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
US5358933A (en) Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
JPH08504210A (ja) 結合生物活性ペプチドを使用した敗血症性ショックの治療
WO2006001542A1 (ja) 毒素中和性ペプチドのスクリーニング方法とｓｔｘ２阻害性ペプチド並びにベロ毒素中和剤
JP3274225B2 (ja) アミノ酸誘導体及びその用途
JPH07509714A (ja) ペプチド肺表面活性剤及び治療用組合せ
WO1999043357A1 (en) Indolicidin and cationic peptides conjugated with polymers
EP0149581B1 (fr) Nouvelles compositions contenant des oligo-muramylpeptides et leur application, notamment pour l'activation des macrophages
JPH06505001A (ja) ２ａ因子阻害剤
JPH04221397A (ja) 水溶性ポリペプチド誘導体とその用途
IE64444B1 (en) New adamantyl comprising tripeptides derivatives and hydrochlorides thereof their preparation and use
Birr Synthetic small thymic peptides: an immunoregulatory concept
JPS60155195A (ja) 新規合成ペプチド、その製法及びそれを含む医薬
RU2146681C1 (ru) Опиоидные пептиды и фармацевтическая композиция

Legal Events

Date Code Title Description
MM4A Patent lapsed